SEQUOIA FINANCIAL GROUP LTD — Capital/Financing Update 2014

Jun 11, 2014

12 June 2014

==> picture [275 x 76] intentionally omitted <==

ASX Announcement & Media Release

MDS Financial Group Limited

Rights Issue Correction

ACN 091 744 884

Level 37

Rialto South Tower 525 Collins Street Melbourne VIC 3000

T: +61 3 9617 0600 F: +61 3 9617 0699 asx@mdsfi nancial.com.au

The timetable for the upcoming MDS rights issue announced on 10 June 2014 has been amended. Accordingly, the announcement of 10 June 2014 is replaced with the announcement below.

MDS Financial Group Limited announces it will be conducting a non-renounceable pro-rata rights issue at an issue price of $0.002 for each new ordinary share on the basis of one new share for every one share held on the record date, to raise up to the sum of $1.030 million. The company will issue a maximum of 515,083,001 new shares, giving a new total of 1,030,166,002 of shares on issue. It is noted that shareholder approval is not required for the rights issue to proceed.

The timetable for the offer is as follows:

ASX Code: MWS

Directors

Peter Stirling

Chairman and Non-Executive Director

Richard Symon

Executive Director

Jamie Khoo

Independent Non-Executive Director

EVENT	DATE
Announcement of Of er	Tuesday 10 June 2014
Lodgment of Appendix 3B, Of er Document and Cleansing Notice with ASX	Thursday 12 June 2014
Despatch of notices to Shareholders informing them of the Of er	Friday 13 June 2014
Shares quoted on ex-entitlement basis	Monday 16 June 2014
Record Date for determining Entitlements	7pm, Tuesday 17 June 2014
Of er opens - despatch of Of er Document and Entitlement and Acceptance Form	Thursday 19 June 2014
Of er Closing Date	5pm, Monday 30 June 2014
Shares quoted on deferred settlement basis	Tuesday 1 July 2014
Company notif es the ASX of under-subscriptions	Wednesday 2 July 2014
Despatch of holding statements and allotment and issue of New Shares	Friday 4 July 2014

Secretariat

This Timetable is indicative only and subject to change. The Directors reserve the right to vary these dates, including the Closing Date without prior notice, subject to the Listing Rules. Any extension of the Closing Date will have a consequential effect on the anticipated date for allotment and issue of the New Shares.

Andrew Phillips

Company Secretary

515.1 million listed shares

The Directors also reserve the right not to proceed with the whole or part of the Offer any time prior to allotment and issue of the New Shares. In that event, any payments received for Applications will be returned in full without interest. It is also noted that the Directors have up to 90 days from the Closing Date to place any non-allocated rights to third parties.

The purpose of the issue is to provide the company with additional working capital and balance sheet strength to pursue organic growth opportunities.

Yours faithfully

Andrew Phillips Company Secretary

END

==> picture [72 x 24] intentionally omitted <==

==> picture [104 x 22] intentionally omitted <==

==> picture [91 x 27] intentionally omitted <==

==> picture [99 x 23] intentionally omitted <==

==> picture [91 x 26] intentionally omitted <==

Page 1 of 1